TMS and esketamine prior authorization: what the records have to show
Most denied TMS and esketamine requests are not denied on the medicine. They are denied because the letter said "failed multiple antidepressants" and the plan wanted the drug, the dose, the dates and the reason, for each one.
7 minutes to read · updated November 21, 2026
What plans usually ask for
Every plan writes its own policy, and the policy you need is the one for this patient's plan, current this year. Read it. Across commercial policies the same items come up again and again:
- A number of antidepressant trials that did not work. Two is the most common. Some older policies still ask for four.
- From different classes. Usually two classes among those trials, for example an SSRI and an SNRI.
- At an adequate dose. Policies say "generally accepted doses", "the FDA-approved range" or "at or near the maximum". The usual reference point is the dose range on the drug's label.
- For long enough. Four, six or eight weeks per trial, depending on the plan. Six is the most common.
- Or stopped for side effects. Most policies accept a trial that ended because the patient could not tolerate it, whatever the dose and length, if the record says so.
- Sometimes an augmentation trial, such as an antipsychotic or lithium added to an antidepressant.
- Often a trial of psychotherapy.
- A severity score, such as a PHQ-9, HAM-D, MADRS or BDI-II, at or above a threshold.
For esketamine, plans often add that the trials happened in the current episode and that the patient takes an oral antidepressant alongside it. Check how the plan words both.
Where each item is in the outside records
The prior prescriber's first psychiatric evaluation usually has the medication history as a list. That list is the most useful page in the packet and is often the only place the doses and the reasons appear together. Later notes repeat the current medications and rarely the old ones.
Hospital discharge papers say which drugs were stopped or started during the stay and often name the program that came after it, such as an intensive outpatient program. That counts toward the psychotherapy question for some plans, and it is easy to miss because it sits in the plan at the bottom of the page.
Therapy notes, when they were sent, show the type of therapy and the session count. Scores are scattered: a PHQ-9 in one note, a HAM-D in a TMS summary, a BDI-II in a psychology report.
Write each trial the same way
For each drug: the name, the highest dose written, the dates or the length, and the record's own words about why it ended, with the page it came from. "Escitalopram 20 mg daily, 2017 to 2018, no response after 10 weeks (outside record p. 3)" is what a reviewer can tick off. "Failed SSRIs" is not.
Quote the reason rather than paraphrasing it. "Stopped for sexual side effects" in the prescriber's words is evidence of intolerance. Your summary of it is a claim.
When something is missing
If a trial is mentioned without a dose or a length, ask the prior prescriber for the note from when it was started and stopped. If the history says therapy happened but no therapy notes came, request them by date range. A request with the gap named ("the 2019 to 2021 methylphenidate trial: dose and reason stopped") gets answered faster than "all records".
This guide describes common policy language. It is not legal or billing advice, and the plan's current written policy is the rule that applies.